Japan's largest drugmaker Takeda Pharmaceutical is in talks to buy privately-held Swiss rival Nycomed in a deal that could be valued at about $14.2 billion, Bloomberg said, citing two people with knowledge of the matter.
via cnbc.com
Japan's largest drugmaker Takeda Pharmaceutical is in talks to buy privately-held Swiss rival Nycomed in a deal that could be valued at about $14.2 billion, Bloomberg said, citing two people with knowledge of the matter.
No comments:
Post a Comment